Exhibit 99


August 13, 1999

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549

Commissioners:

We are aware that our report dated July 27, 1999 on our review of interim
financial information of Vertex Pharmaceuticals Incorporated (the "Company") as
of and for the period ended June 30, 1999 and included in the Company's
quarterly report on Form 10-Q for the quarter then ended is incorporated by
reference in its registration statements on Form S-8 (File Nos. 33-48030,
33-48348, 33-65742, 33-93224, 33-12325, 333-27011, 333-56179 and 333-79549).
Pursuant to Rule 436(c) under the Securities Act of 1933, this report should
not be considered a part of the registration statement prepared or certified by
us within the meaning of Sections 7 and 11 of that Act.

Very truly yours,


PricewaterhouseCoopers LLP
Boston, MA